New hope for kids with tough leukemia: gentler chemo trial launches
NCT ID NCT07059975
Summary
This study is testing whether swapping two specific chemotherapy cycles in the standard treatment for children with acute myeloid leukemia (AML) is safe and tolerable. The goal is to achieve similar or better survival rates while potentially reducing the risk of severe long-term side effects. Researchers will enroll about 36 children and young adults (ages 1 month to 30 years) who are newly diagnosed and at intermediate or high risk of their cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Texas Children's Cancer and Hematology Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.